134 related articles for article (PubMed ID: 17855454)
1. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer.
Matakidou A; el Galta R; Webb EL; Rudd MF; Bridle H; ; Eisen T; Houlston RS
Hum Mol Genet; 2007 Oct; 16(19):2333-40. PubMed ID: 17855454
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
[TBL] [Abstract][Full Text] [Related]
3. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
[TBL] [Abstract][Full Text] [Related]
5. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis.
Kiyohara C; Takayama K; Nakanishi Y
Lung Cancer; 2006 Dec; 54(3):267-83. PubMed ID: 16982113
[TBL] [Abstract][Full Text] [Related]
7. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes.
Abbasi R; Ramroth H; Becher H; Dietz A; Schmezer P; Popanda O
Int J Cancer; 2009 Sep; 125(6):1431-9. PubMed ID: 19444904
[TBL] [Abstract][Full Text] [Related]
8. Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis.
Dong J; Hu Z; Shu Y; Pan S; Chen W; Wang Y; Hu L; Jiang Y; Dai J; Ma H; Jin G; Shen H
Mol Carcinog; 2012 Jul; 51(7):546-52. PubMed ID: 21739480
[TBL] [Abstract][Full Text] [Related]
9. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
Ryk C; Kumar R; Thirumaran RK; Hou SM
Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
[TBL] [Abstract][Full Text] [Related]
11. Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis.
Yu D; Zhang X; Liu J; Yuan P; Tan W; Guo Y; Sun T; Zhao D; Yang M; Liu J; Xu B; Lin D
Clin Cancer Res; 2008 May; 14(9):2878-86. PubMed ID: 18451256
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.
Su D; Ma S; Liu P; Jiang Z; Lv W; Zhang Y; Deng Q; Smith S; Yu H
Lung Cancer; 2007 May; 56(2):281-8. PubMed ID: 17222938
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
14. Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
Li Y; Liu Z; Liu H; Wang LE; Onodera H; Suzuki A; Suzuki K; Wadhwa R; Elimova E; Sudo K; Shiozaki H; Estrella J; Lee JS; Song S; Tan D; Ajani JA; Wei Q
Carcinogenesis; 2014 Sep; 35(9):2031-8. PubMed ID: 24990617
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.
García-Closas M; Malats N; Real FX; Welch R; Kogevinas M; Chatterjee N; Pfeiffer R; Silverman D; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Chanock S; Yeager M; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):536-42. PubMed ID: 16537713
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.
Sun X; Li F; Sun N; Shukui Q; Baoan C; Jifeng F; Lu C; Zuhong L; Hongyan C; YuanDong C; Jiazhong J; Yingfeng Z
Lung Cancer; 2009 Aug; 65(2):230-6. PubMed ID: 19157633
[TBL] [Abstract][Full Text] [Related]
19. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.
Gurubhagavatula S; Liu G; Park S; Zhou W; Su L; Wain JC; Lynch TJ; Neuberg DS; Christiani DC
J Clin Oncol; 2004 Jul; 22(13):2594-601. PubMed ID: 15173214
[TBL] [Abstract][Full Text] [Related]
20. Significance of amino acid substitution variants of DNA repair genes in radiosusceptibility of cervical cancer patients; a pilot study.
Farkasova T; Gurska S; Witkovsky V; Gabelova A
Neoplasma; 2008; 55(4):330-7. PubMed ID: 18505345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
